Early diagnosis of sepsis using serum biomarkers

Expert Review of Molecular Diagnostics

Volumn 11, Issue 5, 2011, Pages 487-496

  Chan, Terence ^a   Gu, Frank ^a,b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

C reactive protein; infection; point of care testing; procalcitonin; sepsis; serum amyloid A; serum biomarker

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD64 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; MANNAN; PROCALCITONIN; SERUM AMYLOID A; TOLL LIKE RECEPTOR 2;

ASSAY; BACTERIAL INFECTION; BLOOD ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; MYCOSIS; NONHUMAN; POINT OF CARE TESTING; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; STANDARDIZATION; TURBIDIMETRY;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHEMOKINE CXCL10; EARLY DIAGNOSIS; HUMANS; MANNANS; MYCOSES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; SERUM AMYLOID A PROTEIN; VIRUS DISEASES;

EID: 79959772961     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.26     Document Type: Review

References (92)

1. Wang P, Yang Z, He Y, Shu C. Pitfalls in the rapid diagnosis of positive blood culture. Rev. Med. Microbiol. 21(3), 39-43 (2010
2. Kauss IAM, Grion CMC, Cardoso LTQ et al. The epidemiology of sepsis in a Brazilian teaching hospital. Brazilian J. Infect. Dis. 14(3), 264-270 (2010
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29(7), 1303-1310 (2001
4. Cetinkaya M, Ozkan H, Koksal N, Celebi S, Hacimustafaoglu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J. Perinatol. 29(3), 225-231 (2009
5. Zecca E, Barone G, Corsello M et al. Reliability of two different bedside assays for C-reactive protein in newborn infants. Clin. Chem. Lab. Med. 47(9), 1081-1084 (2009
6. Ipek IO, Saracoglu M, Bozaykut A. a(1)-acid glycoprotein for the early diagnosis of neonatal sepsis. J. Matern. Fetal Neonatal Med. 23(7), 617-621 (2010
7. Rego MAC, Martinez FE, Elias J, Mussi-Pinhata MM. Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress. J. Perinat. Med. 38(5), 527-533 (2010
8. Watson RS, Carcillo JA, Linde- Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am. J. Respir. Crit. Care Med. 167(5), 695-701 (2003
9. Cardelli P, Ferraironi M, Amode R et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int. J. Immunopathol. Pharmacol. 21(1), 43-49 (2008
10. Cheng BL, Xie GH, Yao SL et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit. Care Med. 35, 2538-2546 (2007
11. Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J. Pediatr. 75(3), 261-266 (2008
12. Hunter P. Sepsis under siege - a new understanding of sepsis might lead to the development of therapies to treat septic shock. EMBO Rep. 7, 667-669 (2006
13. Desmet SS. The problem of sepsis - an expert report of the European-Society-Of- Intensive-Care-Medicine. Intensive Care Med. 20(4), 300-304 (1994
14. Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr. Opin. Infect. Dis. 21(3), 223-227 (2008
15. Zeitoun AAH, Gad SS, Attia FM, Abu Maziad AS, Bell EF. Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early- and late-onset neonatal sepsis. Scand. J. Infect. Dis. 42(4), 299-305 (2010
16. Nijhuis CSMO, Vellenga E, Daenen SMGJ et al. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med. 29(12), 2157-2161 (2003
17. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit. Care Med. 36(3), 941-952 (2008
18. Oh JS, Kim SU, Oh YM et al. The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration. Am. J. Emerg. Med. 27(7), 859-863 (2009
19. Maubon D, Hamidfar-Roy R, Courby S et al. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J. Infect. 61(4), 335-342 (2010
20. Lannergard A, Larsson A, Friman G, Ewald U. Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections. Acta Paediat. 97(8), 1061-1065 (2008
21. Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL. Procalcitonin levels in surgical patients at risk of candidemia. J. Infect. 60(6), 425-430 (2010
22. Sakr Y, Sponhoz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 36(5), 396-407 (2008
23. von Lilienfeld-Toal M, Lehmann LE, Raadts AD et al. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J. Clin. Microbiol. 47(8), 2405-2410 (2009
24. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit. Care 14(1), R15 (2010
25. Schultz MJ, Determann RM. PCT and sTREM-1: the markers of infection in critically ill patients? Med. Sci. Monit. 14(12), RA241-RA247 (2008
26. Kennon C, Overturf G, Bessman S, Sierra E, Smith KJ, Brann B. Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates. J. Pediatr. 128(6), 765-769 (1996
27. Groselj-Grenc M, Ihan A, Pavcnik- Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 35(11), 1950-1958 (2009
28. Arnon S, Litmanovitz I, Regev RH, Bauer S, Shainkin-Kestenbaum R, Dolfin T. Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis. J. Perinatol. 27(5), 297-302 (2007
29. Arendrup MC, Bergmann OJ, Larsson L, Nielsen HV, Jarlov JO, Christensson B. Detection of candidaemia in patients with and without underlying haematological disease. Clin. Microbiol. Infect. 16(7), 855-862 (2010
30. Bille J. New nonculture-based methods for the diagnosis of invasive candidiasis. Curr. Opin. Crit. Care. 16(5), 460-464 (2010
31. Doherty M, Wallis RS, Zumla A, WHO Tropical Dis. Res. Biomarkers for tuberculosis disease status and diagnosis. Curr. Opin. Pulm. Med. 15(3), 181-187 (2009
32. Marshall JC, Reinhart K, Int. Sepsis Forum. Biomarkers of sepsis. Crit. Care Med. 37(7), 2290-2298 (2009
33. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit. Care Med. 27(3), 498-504 (1999
34. Kim KE, Han JY. Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of bloodstream infection. Korean J. Lab. Med. 30(2), 153-159 (2010).
35. Chiriboga DE, Ma YS, Li WJ et al. Seasonal and sex variation of high-sensitivity C-reactive protein in healthy adults: a longitudinal study. Clin. Chem. 55(2), 313-321 (2009
36. Simon L, Gauvin F, Amre DK, Saint- Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis. 39(2), 206-217 (2004
37. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 112(5), 1054-1060 (2003
38. Lacour AG, Gervaix A, Zamora SA et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur. J. Pediatr. 160(2), 95-100 (2001
39. Agapakis DI, Tsantilas D, Psarris P et al. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia. Respirology 15(5), 796-803 (2010
40. Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med. 27(1), 211-215 (2001
41. Edgar JDM, Gabriel V, Gallimore JR, McMillan SA, Grant J. A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection. BMC Pediatr. 10, 22 (2010
42. Lannergard A, Friman G, Ewald U, Lind L, Larsson A. Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr. 94(9), 1198-1202 (2005
43. Fioretto JR, Martin JG, Kurokawa CS et al. Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock. Inflamm. Res. 59(8), 581-586 (2010
44. dos Anjos BL, Grotto HZW. Evaluation of C-reactive protein and serum amyloid A in the detection of inflammatory and infectious diseases in children. Clin. Chem. Lab. Med. 48(4), 493-499 (2010
45. Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL. Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur. J. Clin. Microbiol. Infect. Dis. 24(4), 272-275 (2005
46. Gibot S, Kolopp-Sarda MN, Bene MC et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann. Intern. Med. 141(1), 9-15 (2004
47. Kajiya T, Orihara K, Hamasaki S et al. Toll-like receptor 2 expression level on monocytes in patients with viral infections: monitoring infection severity. J. Infect. 57(3), 249-259 (2008
48. Lannergard A, Viberg A, Cars O, Karlsson MO, Sandstrom M, Larsson A. The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy. Scand. J. Infect. Dis. 41(9), 663-671 (2009
49. Claessens YE, Schmidt J, Batard E et al. Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin. Microbiol. Infect. 16(6), 753-760 (2010
50. Claessens YE, Mathevon T, Kierzek G et al. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Intensive Care Med. 36(5), 799-809 (2010
51. Whicher JT, Chambers RE, Higginson J, Nashef L, Higgins PG. Acute phase response of serum amyloid-A protein and C-reactive protein to the common cold and influenza. J. Clin. Pathol. 38(3), 312-316 (1985
52. Quint JK, Donaldson GC, Goldring JJP, Baghai-Ravary R, Hurst JR, Wedzicha JA. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. Chest 137(4), 812-822 (2010
53. Nakamura A, Wada H, Ikejiri M et al. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock 31(6), 586-591 (2009
54. Deis JN, Creech CB, Estrada CM, Abramo TJ. Procalcitonin as a marker of severe bacterial infection in children in the emergency department. Pediatr. Emerg. Care 26(1), 51-63 (2010
55. Dong HM, Shu W, Liu TC et al. Targeting procalcitonin with novel murine monoclonal antibodies. Hybridoma 29(3), 189-194 (2010
56. Schuetz P, Christ-Crain M, Huber AR, Muller B. Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin. Biochem. 43(3), 341-344 (2010
57. Manzano S, Bailey B, Girodias JB, Cousineau J, Delvin E, Gervaix A. Comparison of procalcitonin measurement by a semi-quantitative method and an ultra-sensitive quantitative method in a pediatric emergency department. Clin. Biochem. 42(15), 1557-1560 (2009
58. Limper M, de Kruif MD, Duits AJ, Brandjes DPM, van Gorp ECM. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J. Infect. 60(6), 409-416 (2010
59. Oshita H, Sakurai J, Kamitsuna M. Semi-quantitative procalcitonin test for the diagnosis of bacterial infection: clinical use and experience in Japan. J. Microbiol. Immunol. Infect. 43(3), 222-227 (2010
60. Wunderink RG. Surrogate markers and microbiologic end points. Clin. Infect. Dis. 51, S126-S130 (2010
61. Dubos F, Moulin F, Gajdos V et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J. Pediatr. 149(1), 72-76 (2006
62. Pavic M, Bronic A, Kopcinovic LM. Procalcitonin in systemic and localized bacterial infection. Biochemia Medica 20(2), 236-241 (2010
63. Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J. Clin. Microbiol. 48(7), 2325-2329 (2010
64. Schneider CP, Yilmaz Y, Kleespies A, Jauch KW, Hartl WH. Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock 31(6), 568-573 (2009).
65. Lopez AF, Cubells CL, Garcia JJG, Pou JF. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr. Infect. Dis. J. 22(10), 895-903 (2003
66. Kelly D, Khan SQ, Dhillon O et al. Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers 15(4), 325-331 (2010
67. Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Criti. Care 14(1), 203 (2010
68. Mira JP, Max A, Burgel PR. The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy. Critical Care 12(Suppl. 6), S5 (2008
69. Cetinkaya M, Ozkan H, Koksal N, Akaci O, Ozgur T. The efficacy of serial serum amyloid A measurements for diagnosis and follow-up of necrotizing enterocolitis in premature infants. Pediatr. Surg. Int. 26(8), 835-841 (2010
70. Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J. Med. Microbiol. 58(5), 606-615 (2009
71. Sendid B, Jouault T, Coudriau R et al. Increased sensitivity of mannanemia detection tests by joint detection of a- and b-linked oligomannosides during experimental and human systemic candidiasis. J. Clin. Microbiol. 42(1), 164-171 (2004
72. Ng PC, Li K, Chui KM et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr. Res. 61(1), 93-98 (2007
73. Sumino KC, Walter MJ, Mikols CL et al. Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness. Thorax 65(7), 639-644 (2010
74. Wang JA, Wang PP, Xiang GJ, Hu XB. Relationship between the expression of IP-10 and IP-10 mRNA in peripheral blood and HBV DNA level in patients with cirrhosis. Hepatobiliary Pancreat. Dis. Int. 9(3), 280-286 (2010
75. Lagging M, Romero AI, Westin J et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44(6), 1617-1625 (2006
76. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med. 33(6), 1025-1032 (2007
77. Nuutila J, Hohenthal U, Laitinen L et al. Simultaneous quantitative analysis of Fc?RI (CD64) expression on neutrophils and monocytes: a new, improved way to detect infections. J. Immunol. Methods 328(1-2), 189-200 (2007
78. Nuutila J. The novel applications of the quantitative analysis of neutrophil cell surface Fc g RI (CD64) to the diagnosis of infectious and inflammatory diseases. Curr. Opin. Infect. Dis. 23(3), 268-274 (2010
79. Cid J, Aguinaco R, Sanchez R, Garcia-Pardo G, Llorente A. Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J. Infect. 60(5), 313-319 (2010
80. Hoffmann JJML. Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin. Chem. Lab. Med. 47(8), 903-916 (2009
81. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin. Chem. Lab. Med. 41(1), 68-73 (2003
82. Bossuyt PM, Reitsma JB, Bruns DE et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 49(1), 7-18 (2003
83. Schunemann HJ, Oxman AD, Brozek J et al. GRADE: assessing the quality of evidence for diagnostic recommendations. Evid. Based Med. 13(6), 162-3 (2008
84. Schunemann HJ, Schunemann AHJ, Oxman AD et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336(7653), 1106-1110 (2008
85. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu. Rev. Biomed. Eng. 10, 107-144 (2008
86. Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin. Microbiol. Infect. 16(8), 1062-1069 (2010
87. Aguilera-Herrador E, Cruz-Vera M, Valcarcel M. Analytical connotations of point-of-care testing. Analyst 135(9), 2220-2232 (2010
88. Rusling JF, Kumar CV, Gutkind JS, Patel V. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst 135(10), 2496-2511 (2010
89. Mtapuri-Zinyowera S, Chideme M, Mangwanya D et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J. Acquir. Immune Defic. Syndr. 55(1), 1-7 (2010
90. Wilkins J, Gallimore JR, Moore EG, Pepys MB. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin. Chem. 44(6), 1358-1361 (1998
91. Chourrout P. Procalcitonin: from discovery to clinical use. Medecine Nucleaire- Imagerie Fonctionnelle et Metabolique 32(3), 132-137 (2008
92. Wilkins J, Gallimore JR, Tennent GA et al. Rapid automated enzyme-immunoassay of serum amyloid-A. Clin. Chem. 40(7), 1284-1290 (1994).